stockrow
Friday 6 November 2026
Export USPH’s income statement to Excel — free account
U.S. Physical Therapy, Inc.
USPH Healthcare Medical Care Facilities
U.S. Physical Therapy, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $781.0 million, up 16.3% from fiscal 2024.
- Revenue
- +12.9%
- EPS
- −316.7%
- Free cash flow
- +32.2%
- Total debt
- +59.6%
Quarter to September 2026, against a year earlier
99.88
2.68
+2.76%
Follow USPH
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 404.00 | 149.92 | 54.99 |
+8 more quarters Free account |
P/S ratio |
1.53 | 1.27 | 1.43 | 1.52 | |
P/FCF ratio |
18.52 | 16.15 | 17.05 | 19.43 | |
P/Operating CF |
49.75 | 30.11 | 298.56 | 47.53 | |
P/B ratio |
2.98 | 2.30 | 2.42 | 2.48 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.77 | 1.51 | 1.64 | 1.67 | |
EV/EBITDA |
14.93 | 12.34 | 12.71 | 11.89 | |
EV/Operating CF |
16.70 | 14.76 | 15.59 | 17.35 | |
EV/FCF |
21.47 | 19.13 | 19.54 | 21.35 | |
Quick Ratio |
1.24 | 1.12 | 1.07 | 0.89 | |
Current Ratio |
1.42 | 1.27 | 1.19 | 1.01 | |
Net Debt/EBITDA |
0.00 | 6.81 | 8.91 | 5.44 | |
Debt/Assets |
18.65% | 17.25% | 15.62% | 12.67% | |
Debt/Equity |
0.56 | 0.48 | 0.41 | 0.32 | |
Asset Turnover |
0.67 | 0.67 | 0.66 | 0.66 | |
Operating CF/Net income |
0.00 | 9.03 | (2.07) | 4.48 | |
Capex/Depreciation |
0.00 | (0.89) | (0.88) | (0.83) | |
Interest Coverage |
— | 6.83 | 4.47 | 7.13 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8.01% | 8.88% | 9.22% | 8.94% | |
Intangible Assets out of Total Assets |
0.70 | 0.72 | 0.72 | 0.72 | |
Share Based Compensation of Revenue |
1.35% | 1.48% | 1.16% | 1.05% | |
Graham Net Nets |
(0.56) | (0.64) | (0.56) | (0.50) | |
Graham Number |
0.00 | 10.68 | 18.66 | 31.69 | |
Earnings Yield |
(1.57%) | 0.25% | 0.67% | 1.82% | |
Free Cash Flow Yield |
5.40% | 6.19% | 5.86% | 5.15% | |
Revenue per Share |
14.91 | 14.20 | 13.07 | 13.36 | |
Operating CF per Share |
1.72 | 2.28 | 0.25 | 1.64 | |
Capex per Share |
(0.34) | (0.36) | (0.35) | (0.26) | |
Free Cash Flow per Share |
1.38 | 1.92 | (0.10) | 1.38 | |
Cash per Share |
2.56 | 1.65 | 1.88 | 2.34 | |
Shareholders Equity per Share |
28.81 | 29.81 | 30.95 | 31.43 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
28.81 | 29.81 | 30.95 | 31.43 | |
Free Cash Flow |
20.65 | 29.01 | (1.56) | 21.01 | |
Working Capital |
45.54 | 29.77 | 21.81 | 0.95 | |
Capital Expenditures |
(5.07) | (5.36) | (5.37) | (3.93) | |
Net Current Asset Value |
(710.90) | (660.03) | (633.51) | (587.13) | |
EV/EBIT |
19.38 | 16.02 | 16.38 | 15.02 | |
Capex to Sales |
0.02 | 0.03 | 0.03 | 0.02 | |
Price to Operating Income |
16.72 | 13.53 | 14.30 | 13.67 | |
| Other line items | |||||
Average Receivables |
94.35 | 95.77 | 93.81 | 87.00 | |
Average Payables |
6.39 | 5.56 | 6.42 | 6.00 | |
Average Assets |
1,246.01 | 1,214.24 | 1,210.87 | 1,185.74 | |
Average Common Equity |
467.43 | 475.73 | 484.20 | 483.45 |
Columns are period end dates · fundamentals updated 5 Nov 2026